LAMB2 and pancreatic neoplasm: This bioinformatics analysis of the laminin gene family and PAAD showed LM332 genes to be prognostic markers, predicting patient outcomes and drug responsiveness, and assessing their expression can be used to improve pancreatic cancer patient stratification and therapy choices.